EP0533837A4 - Inhibition of 5-lipoxygenase and cyclooxygenase pathway mediated diseases - Google Patents
Inhibition of 5-lipoxygenase and cyclooxygenase pathway mediated diseasesInfo
- Publication number
- EP0533837A4 EP0533837A4 EP19910912750 EP91912750A EP0533837A4 EP 0533837 A4 EP0533837 A4 EP 0533837A4 EP 19910912750 EP19910912750 EP 19910912750 EP 91912750 A EP91912750 A EP 91912750A EP 0533837 A4 EP0533837 A4 EP 0533837A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- lipoxygenase
- inhibition
- mediated diseases
- pathway mediated
- cyclooxygenase pathway
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US53719590A | 1990-06-12 | 1990-06-12 | |
US537195 | 1990-06-12 | ||
PCT/US1991/004022 WO1991019497A1 (en) | 1990-06-12 | 1991-06-07 | Inhibition of 5-lipoxygenase and cyclooxygenase pathway mediated diseases |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0533837A1 EP0533837A1 (en) | 1993-03-31 |
EP0533837A4 true EP0533837A4 (en) | 1994-11-17 |
Family
ID=24141624
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19910912750 Withdrawn EP0533837A4 (en) | 1990-06-12 | 1991-06-07 | Inhibition of 5-lipoxygenase and cyclooxygenase pathway mediated diseases |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0533837A4 (en) |
JP (1) | JPH05508153A (en) |
KR (1) | KR930700104A (en) |
AU (1) | AU8205991A (en) |
CA (1) | CA2084290A1 (en) |
IE (1) | IE911977A1 (en) |
NZ (1) | NZ238485A (en) |
PT (1) | PT97960A (en) |
WO (1) | WO1991019497A1 (en) |
ZA (1) | ZA914491B (en) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0679396A1 (en) * | 1994-03-02 | 1995-11-02 | Pfizer Inc. | Use of 3-substituted-2-oxidole-1-carboxamides for the manufacture of a medicament in the treatment and prevention of ischemia induced myocardial injury and cytokine mediated myocardial injury |
US5552422A (en) * | 1995-01-11 | 1996-09-03 | Merck Frosst Canada, Inc. | Aryl substituted 5,5 fused aromatic nitrogen compounds as anti-inflammatory agents |
AU6111796A (en) * | 1995-06-12 | 1997-01-09 | G.D. Searle & Co. | Compositions comprising a cyclooxygenase-2 inhibitor and a 5 -lipoxygenase inhibitor |
US7301021B2 (en) | 1997-07-02 | 2007-11-27 | Smithkline Beecham Corporation | Substituted imidazole compounds |
ATE317845T1 (en) | 1997-09-05 | 2006-03-15 | Glaxo Group Ltd | PHARMACEUTICAL COMPOSITION CONTAINING 2,3-DIARYL-PYRAZOLO(1,5-B)PYRIDAZINE DERIVATIVES |
EP1037639A4 (en) | 1997-12-19 | 2002-04-17 | Smithkline Beecham Corp | Compounds of heteroaryl substituted imidazole, their pharmaceutical compositions and uses |
US6858617B2 (en) | 1998-05-26 | 2005-02-22 | Smithkline Beecham Corporation | Substituted imidazole compounds |
CA2341370A1 (en) | 1998-08-20 | 2000-03-02 | Smithkline Beecham Corporation | Novel substituted triazole compounds |
KR20010075673A (en) | 1998-11-03 | 2001-08-09 | 그레이엄 브레레톤, 레슬리 에드워즈 | Pyrazolopyridine Derivatives as Selective COX-2 Inhibitors |
AU1909200A (en) | 1998-11-04 | 2000-05-22 | Smithkline Beecham Corporation | Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines |
AU2661400A (en) | 1999-02-27 | 2000-09-21 | Glaxo Group Limited | Pyrazolopyridines |
HUP0200207A3 (en) * | 1999-11-10 | 2004-07-28 | Ortho Mcneil Pharm Inc | Substituted 2-aryl-3-(hetroaryl)-imidazo [1,2-a] pyrimidines, and related pharmaceutical compositions and methods for their preparation |
DE60023025T2 (en) | 1999-11-23 | 2006-07-13 | Smithkline Beecham Corp. | 3,4-DIHYDRO- (1H) CHINAZOLIN-2-ON COMPOUNDS AS CSBP / P39 KINASE INHIBITORS |
ATE281439T1 (en) | 1999-11-23 | 2004-11-15 | Smithkline Beecham Corp | 3,4-DIHYDRO-(1H)CHINAZOLINE-2-ONE COMPOUNDS AS CSBP/P38 KINASE INHIBITORS |
US6759410B1 (en) | 1999-11-23 | 2004-07-06 | Smithline Beecham Corporation | 3,4-dihydro-(1H)-quinazolin-2-ones and their use as CSBP/p38 kinase inhibitors |
ES2241675T3 (en) | 1999-11-23 | 2005-11-01 | Smithkline Beecham Corporation | 3,4-DIHIDRO- (1H) QUINAZOLIN-2-ONA COMPOUNDS AS CSPB / P38 QUINASA INHIBITORS. |
GB9930358D0 (en) | 1999-12-22 | 2000-02-09 | Glaxo Group Ltd | Process for the preparation of chemical compounds |
US7235551B2 (en) | 2000-03-02 | 2007-06-26 | Smithkline Beecham Corporation | 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases |
PE20020506A1 (en) | 2000-08-22 | 2002-07-09 | Glaxo Group Ltd | PIRAZOLE DERIVATIVES FUSED AS PROTEIN KINASE INHIBITORS |
EP1341788B1 (en) | 2000-12-15 | 2005-08-10 | Glaxo Group Limited | Pyrazolopyridines |
ES2243579T3 (en) | 2000-12-15 | 2005-12-01 | Glaxo Group Ltd | DERIVATIVES OF PIRAZOLOPIRIDENO. |
JP2004529119A (en) | 2001-03-08 | 2004-09-24 | スミスクライン ビーチャム コーポレーション | Pyrazolopyridine derivative |
US6596731B2 (en) | 2001-03-27 | 2003-07-22 | Hoffmann-La Roche Inc. | Substituted imidazo[1,2-A] pyridine derivatives |
US7034030B2 (en) | 2001-03-30 | 2006-04-25 | Smithkline Beecham Corporation | Pyralopyridines, process for their preparation and use as therapeutic compounds |
ATE332301T1 (en) | 2001-04-10 | 2006-07-15 | Smithkline Beecham Corp | ANTIVIRAL PYRAZOLOPYRIDINE COMPOUNDS |
ATE296826T1 (en) | 2001-04-27 | 2005-06-15 | Smithkline Beecham Corp | PYRAZOLO(1,5)PYRIDINE DERIVATIVES |
US6756498B2 (en) | 2001-04-27 | 2004-06-29 | Smithkline Beecham Corporation | Process for the preparation of chemical compounds |
CZ20033518A3 (en) | 2001-06-21 | 2004-05-12 | Smithklineábeechamácorporation | Imidazo(1,2-a)pyridine derivatives for the prophylaxis and treatment of herpes viral infections |
JP2005508955A (en) | 2001-10-05 | 2005-04-07 | スミスクライン ビーチャム コーポレーション | Imidazo-pyridine derivatives for use in the treatment of herpesvirus infections |
ES2292839T3 (en) | 2001-12-11 | 2008-03-16 | Smithkline Beecham Corporation | DERIVATIVES OF PIRAZOLO-PIRIDINA AS AGENTS AGAINST HERPES. |
AU2003275266A1 (en) | 2002-10-03 | 2004-05-04 | Smithkline Beecham Corporation | Therapeutic compounds based on pyrazolopyridine derivatives |
EP1928237A4 (en) | 2005-09-02 | 2011-03-09 | Abbott Lab | Novel imidazo based heterocycles |
EP2170337A4 (en) | 2007-06-28 | 2013-12-18 | Abbvie Inc | Novel triazolopyridazines |
ES2651296T3 (en) | 2009-10-30 | 2018-01-25 | Janssen Pharmaceutica, N.V. | Imidazo [1,2-b] pyridacin derivatives and their use as PDE10 inhibitors |
CA2782601C (en) | 2009-12-18 | 2015-07-21 | Mitsubishi Tanabe Pharma Corporation | Novel antiplatelet agent |
AR080754A1 (en) | 2010-03-09 | 2012-05-09 | Janssen Pharmaceutica Nv | IMIDAZO DERIVATIVES (1,2-A) PIRAZINA AND ITS USE AS PDE10 INHIBITORS |
CN103649079B (en) | 2010-12-22 | 2016-11-16 | Abbvie公司 | Hepatitis c inhibitor and application thereof |
MX344600B (en) | 2011-06-27 | 2016-12-20 | Janssen Pharmaceutica Nv | 1-ARYL-4-METHYL-[1,2,4]TRIAZOLO[4,3-a]QUINOXALINE DERIVATIVES. |
EP2863909B1 (en) | 2012-06-26 | 2020-11-04 | Janssen Pharmaceutica N.V. | Combinations comprising 4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline compounds as pde 2 inhibitors and pde 10 inhibitors for use in the treatment of neurological or metabolic disorders |
AU2013289284B2 (en) | 2012-07-09 | 2017-03-30 | Janssen Pharmaceutica Nv | Inhibitors of phosphodiesterase 10 enzyme |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0231622A2 (en) * | 1985-12-12 | 1987-08-12 | Smithkline Beecham Corporation | Inhibition of the 5-lipoxygenase pathway |
EP0364204A1 (en) * | 1988-10-11 | 1990-04-18 | Smithkline Beecham Corporation | Pyrrolo[1,2-a]imidazole and imidazo[1,2-a]pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors |
EP0411754A2 (en) * | 1989-06-13 | 1991-02-06 | Smithkline Beecham Corporation | Medicament for the inhibition of interleukin-1 or tumor necrosis factor production by monocytes and/or macrophages |
-
1991
- 1991-06-07 WO PCT/US1991/004022 patent/WO1991019497A1/en not_active Application Discontinuation
- 1991-06-07 CA CA002084290A patent/CA2084290A1/en not_active Abandoned
- 1991-06-07 KR KR1019920703188A patent/KR930700104A/en not_active Application Discontinuation
- 1991-06-07 EP EP19910912750 patent/EP0533837A4/en not_active Withdrawn
- 1991-06-07 AU AU82059/91A patent/AU8205991A/en not_active Abandoned
- 1991-06-07 JP JP91512077A patent/JPH05508153A/en active Pending
- 1991-06-10 ZA ZA914491A patent/ZA914491B/en unknown
- 1991-06-11 IE IE197791A patent/IE911977A1/en unknown
- 1991-06-11 NZ NZ238485A patent/NZ238485A/en unknown
- 1991-06-12 PT PT97960A patent/PT97960A/en not_active Application Discontinuation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0231622A2 (en) * | 1985-12-12 | 1987-08-12 | Smithkline Beecham Corporation | Inhibition of the 5-lipoxygenase pathway |
EP0364204A1 (en) * | 1988-10-11 | 1990-04-18 | Smithkline Beecham Corporation | Pyrrolo[1,2-a]imidazole and imidazo[1,2-a]pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors |
EP0411754A2 (en) * | 1989-06-13 | 1991-02-06 | Smithkline Beecham Corporation | Medicament for the inhibition of interleukin-1 or tumor necrosis factor production by monocytes and/or macrophages |
Non-Patent Citations (1)
Title |
---|
See also references of WO9119497A1 * |
Also Published As
Publication number | Publication date |
---|---|
NZ238485A (en) | 1994-03-25 |
AU8205991A (en) | 1992-01-07 |
CA2084290A1 (en) | 1991-12-13 |
WO1991019497A1 (en) | 1991-12-26 |
ZA914491B (en) | 1992-12-30 |
EP0533837A1 (en) | 1993-03-31 |
JPH05508153A (en) | 1993-11-18 |
IE911977A1 (en) | 1991-12-18 |
PT97960A (en) | 1992-03-31 |
KR930700104A (en) | 1993-03-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0533837A4 (en) | Inhibition of 5-lipoxygenase and cyclooxygenase pathway mediated diseases | |
EP0484142A3 (en) | Micro-machined switch and method of fabrication | |
IL112041A0 (en) | Methods of inhibiting atrophy of the skin and vagina | |
EP0257756A3 (en) | Prevention of fusarium diseases and microorganisms therefor | |
GB9301802D0 (en) | Manufacture and processing of components | |
ZA911101B (en) | Inhibition of modified ldl products | |
KR100321237B1 (en) | Laminate and use of the same | |
EP0586687A4 (en) | Trans-sialidase and methods of use and making thereof | |
ZA869347B (en) | Inhibition of the 5-lipoxygenase pathway | |
GB9111216D0 (en) | Tissue dispenser and method of making the same | |
GB2286120B (en) | Therapeutic pepper extracts and related compounds | |
EP0702080A3 (en) | Azeotropes of octamethyltri-siloxane and n-propoxypropanol | |
PL311300A1 (en) | 4-arylo-4-hydroxy-tetrahydropyranes and 3-arylo-3-hydroxy-tetrahydrofuranes as inhibitors of 5-lipoxygenase | |
GB2240310B (en) | Double acting switch and method of use | |
NZ242876A (en) | Stealth viruses and detection of associated diseases | |
NO930678D0 (en) | COOLING WATER INPUT AND PROCEDURE FOR THE PREPARATION OF A COOLING WATER BODY | |
PT83903B (en) | Inhibition of the 5-lipoxygenase pathway | |
EP0323645A3 (en) | Extract of chlorella and use thereof | |
AU8083591A (en) | Therapy and prophylaxis of autoimmune diseases | |
NO952194D0 (en) | Spirofuranone derivatives and their use in the treatment of neurodegenerative diseases | |
GB2265366B (en) | Treatment of waste | |
ZA935409B (en) | Inorganic perbromide compositions and methods of use thereof | |
GB2262520B (en) | Films of KTN and KTaO3 | |
LTIP164A (en) | Composition of extract | |
IE901061L (en) | Preparation of 3-exomethylcepham sulfoxides and of¹2-chlorosulfinylazetidin-4-ones |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19921216 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 19940928 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 19941219 |